In addition, the molecular and genetic features of a cohort of 87 patients with high-grade serous ovarian cancer (HGSOC) harboring BRCA1/2 mutations without reversion mutations were compared with those of 14 patients with HGSOC and reversion mutations. Here, BRCA1 is linked to ovarian serous adenocarcinoma.